Search

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:

… Friday, August 15, 2025 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:  MSK’s financial performance for the first half of 2025 resulted in a deficiency of operating revenues over expenses of $(113.2) million

Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.

… Tuesday, May 31, 2022 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, June 3

The Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center's Gerstner Sloan Kettering Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI's Med into Grad Initiative.

… Monday, November 30, 2009 In November the Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center’s Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI’s Med into Grad Initiative

President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board. Memorial Sloan Kettering Cancer Center’s Luis Alberto Diaz, Jr., MD, was among those appointed.

… Thursday, September 16, 2021 President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board, which plays an important role in guiding the Director of the National Cancer Institute in setting the course for the national cancer research

Learn how researchers engineered CAR T cells to work better by using a mutation in a gene called c-KIT that drives cancer cell growth.

… Monday, June 19, 2023 Chimeric antigen receptor (CAR) T cell therapy , an immunotherapy that uses genetically modified immune cells, has shown great promise for the treatment of blood cancers such as  leukemia  and  lymphoma . However, this type of immunotherapy has so far been much less effective against

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

… Wednesday, November 13, 2013 Summary The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops. The 1986 Chernobyl nuclear power plant disaster was the worst nuclear accident

Cards are a longstanding Valentine’s tradition — and The Scarlett Fund, with help from Memorial Sloan Kettering Cancer Center employees, is using cards to make sure that patients and staff will be feeling the love for a long time to come.

… Tuesday, February 15, 2022 Jason holding a card Jason Giani, a patient of Jia Li at MSK Commack, received about 100 cards. Elizabeth Rodriguez, Diane Reidy, and Jennifer Tota posing with cards Elizabeth Rodriguez (left), Diane Reidy-Lagunes (center), and Jennifer Tota delivered cards to patients and

Gift from Jamie C. Nicholls and O. Francis Biondi will support MSK’s commitment to disparities research, expanded access to cancer care for underserved communities, and training diverse leaders in oncology.

… Monday, February 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) today announced the newly established Nicholls-Biondi Chair for Health Equity . This permanently endowed chair is dedicated to improving outcomes for patients from medically underserved communities and building a base of knowledge

Because people with cancer have a higher-than-normal risk of developing infections, our infection control experts have developed a number of innovative programs.

… Tuesday, October 18, 2016 Summary Because cancer treatments can weaken the immune system, infections are a common complication during cancer treatment. MSK has implemented a number of programs to protect patients from infections. One of the biggest complications for people receiving chemotherapy , especially

This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.

… Thursday, June 8, 2023 You may have heard the terms “gut microbiota” and “microbiome” and wondered what they mean and why they matter. Many researchers at Memorial Sloan Kettering Cancer Center (MSK) are studying how they influence the health of people with cancer and the general population, too. Here